A new frontier for R-CHOP: is two better than one?
Blood
.
2023 Oct 19;142(16):1331-1332.
doi: 10.1182/blood.2023021521.
Authors
Umberto Vitolo
1
,
Annalisa Chiappella
2
Affiliations
1
Candiolo Cancer Institute, FPO-IRCCS.
2
Fondazione IRCCS, Istituto Nazionale dei Tumori.
PMID:
37856095
DOI:
10.1182/blood.2023021521
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cyclophosphamide
Lenalidomide*
Prednisone / therapeutic use
Rituximab / therapeutic use
Vincristine
Substances
Lenalidomide
tafasitamab
Rituximab
Vincristine
Cyclophosphamide
Prednisone